International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7797301
Original Article
Association Between Risk Factors and Still Birth in Pregnancy in Tertiary Care Center
 ,
 ,
Published
April 4, 2023
Abstract
Introduction: Stillbirth is a sensitive indicator of maternal care during the antepartum and intrapartum period. Globally around 2.6 million stillbirths occurred in 2019 out of which India accounting for 22%. Aims and Objectives: 1.To correlate the association between stillbirth in pregnancy and risk factor in tertiary care center.2.To assess the modifiable risk factors and propose preventable strategies. Methods: A Hospital based Retrospective clinical study carried out in Department of Obstetrics and Gynaecology of Sapthagiri Institute of Medical Sciences and Research Centre, Bengaluru for three years from October 2018-October 2021. Results: Young primigravida’s were more at risk of having a stillbirth. Obesity and smoking did not play a major in this study. Majority of the cases were pre-term 78.18%. Hypertensive disorder in pregnancy 36.36% was the leading cause of fetal death. Antepartum hemorrhageand anemia accounted for 14.54%, Rh negative pregnancy and endocrine dysfunction accounted for 9% of still birth. None of the cases had any screening strategies done, example: pre-eclampsia, diabetes, or thyroid studies. Conclusion: Highest prevalent risk factors associated with stillbirths are hypertension and prematurity. There is a need to provide and assure access to specialized quality antenatal care to pregnant women to control and modify where feasible the risk factors associated with stillbirths. Implementation of available screening strategies especially for hypertensive disorder in pregnancy and gestational diabetes mellitus will help in modifying fetal and neonatal outcomes.
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
2594 Views
462 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved